REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,254,000 | -28.9% | 12,465 | 0.0% | 0.33% | -27.5% |
| Q2 2021 | $1,764,000 | +41.9% | 12,465 | 0.0% | 0.45% | +31.2% |
| Q1 2021 | $1,243,000 | +9.7% | 12,465 | +49.0% | 0.35% | -0.9% |
| Q4 2020 | $1,133,000 | -4.1% | 8,365 | -31.0% | 0.35% | -15.9% |
| Q3 2020 | $1,181,000 | – | 12,125 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
| Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
| MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
| Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
| Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
| Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
| Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
| Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |